Deflazacort Oral Suspension (deflazacort) NDC 70710-2007

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-2007Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-2007Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-2007-3	70710200703	1 BOTTLE in 1 CARTON (70710-2007-3) / 13 mL in 1 BOTTLEMarketed from Oct 23, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Deflazacort Oral Suspension
Generic name (nonproprietary): deflazacort
Active ingredients: Deflazacort — 22.75 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Zydus Pharmaceuticals (USA) Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220042
Marketing start: Oct 23, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70710-2007_ac6be220-ebff-4cc0-9eff-dcd452eab805SPL ID ac6be220-ebff-4cc0-9eff-dcd452eab805
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710200703 followed by a unit qualifier and the quantity

Package 70710-2007-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 220042

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220042
Product	Strength	Form · route	Labeler	Product NDC
Deflazacort Oral Suspensiondeflazacort	Deflazacort 22.75 mg/mL	SuspensionOral	Doppel Farmaceutici S.r.l.	81806-200
JAYTHARI Oral Suspensiondeflazacort	Deflazacort 22.75 mg/mL	SuspensionOral	Doppel Farmaceutici S.r.l.	81806-213
JAYTHARI Oral Suspensiondeflazacort	Deflazacort 22.75 mg/mL	SuspensionOral	Zydus Pharmaceuticals (USA) Inc.	70710-2131